DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Petrylak DP, Tangen CM, Hussain MH, Lara Jr. PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED.
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
N Engl J Med 2004;
351: 1513-1520
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.